Possible Clarification on the Pivotal Trial of Ibrutinib (PCI-32765) Concerning 17p deletion
Labels: 17p deletion, ibrutinib, PCI-32765
What started as a personal journey of a doctor turned patient morphed into a way to share what’s universal in dealing with cancer, in my case a nasty leukemia (CLL), a failed transplant and a successful clinical trial. The telling of my journey has become a journey to teach about CLL, related blood issues and all cancers. Please visit our new website http://cllsociety.org for the latest news and information. Smart patients get smart care™. If you want to reach me, email bkoffmanMD@gmail.com
Labels: 17p deletion, ibrutinib, PCI-32765
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home